Innovations in phase 1 trial design: where do we go next?
Collins
J M
JM
D000970:Antineoplastic Agents / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic / Q000379:methods* / Q000639:trends*; D006801:Humans; D020714:Maximum Tolerated Dose; D009369:Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents